Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study

Abstract

Catheter-related thrombosis (CRT) poses serious risks for cancer patients. Identifying risk factors and implementing targeted interventions can prevent CRT. To explore thromboelastogram parameters and clinical risk factors for CRT in elderly lung cancer patients. A total of 663 elderly lung cancer patients were selected from three hospitals in Hunan, Hainan, and Qinghai provinces in China from January 1, 2022, to June 30, 2024. The patients were divided into two groups: a CRT group (221 patients) and a non-CRT group (442 patients), with a ratio of 1:2. A between-group comparison and binary logistic regression were used to analyze risk factors for CRT in elderly lung cancer patients. Binary logistic regression analysis showed that decreased R (odds ratio [OR]: 0.849, 95% confidence interval [CI]: 0.763–0.945, p = 0.003), decreased K (0.571, 95% CI: 0.404–0.807, p = 0.001), advanced age (OR: 1.073, 95% CI: 1.033–1.113, p < 0.001), elevated platelet count (OR: 1.006, 95% CI: 1.004–1.009, p < 0.001), increased hemoglobin level (OR: 1.020, 95% CI: 1.009–1.031, p < 0.001), shortened PT (OR: 0.904, 95% CI: 0.830–0.985, p = 0.022), surgery ≤ 1 month (OR: 2.258, 95% CI: 1.420–3.590, p = 0.001), male sex (OR: 4.534, 95% CI: 2.815–7.304, p < 0.001), diabetes (OR: 2.478, 95% CI: 1.373–4.472, p = 0.003), hypertension (OR: 2.386, 95% CI: 1.505–3.784, p < 0.001), physical activity disorders (OR: 9.038, 95% CI: 4.462–18.309, p < 0.001) were independent risk factors for CRT in elderly lung cancer patients. Independent risk factors for CRT in elderly lung cancer patients include decreased K-values and decreased R-values, shortened PT, advanced age, elevated platelet count, increased hemoglobin level, surgery ≤ 1 month, male sex, diabetes, hypertension, and physical activity disorders.

Keywords

catheter-related thrombosis - elderly patients - lung cancer - thromboelastography - risk factors

• References

• 1 Mederos N, Friedlaender A, Peters S, Addeo A. Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer. ESMO Open 2020; 5 (Suppl. 04) e000796
• 2 Bray F, Laversanne M, Sung H. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74 (03) 229-263
• 3 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
• 4 Huang J, Deng Y, Tin MS. et al. Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: a global analysis. Chest 2022; 161 (04) 1101-1111
• 5 Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health 2019; 85 (01) 1-16
• 6 Gao S, Li N, Wang S. et al. Lung cancer in People's Republic of China. J Thorac Oncol 2020; 15 (10) 1567-1576
• 7 Fan-Ying M, Lei Y, Xiao-Tong MA, Hui-Xin S. Incidence and mortality of cancer in elderly population in China. J Evid Based Med 2023; 23: 169-173
• 8 Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res 2020; 187: 103-112
• 9 Akhtar N, Lee L. Utilization and complications of central venous access devices in oncology patients. Curr Oncol 2021; 28 (01) 367-377
• 10 Abbruzzese C, Guzzardella A, Consonni D. et al. Incidence of asymptomatic catheter-related thrombosis in intensive care unit patients: a prospective cohort study. Ann Intensive Care 2023; 13 (01) 106
• 11 Liu B, Xie J, Sun X. et al. Development and validation of a new clinical prediction model of catheter-related thrombosis based on vascular ultrasound diagnosis in cancer patients. Front Cardiovasc Med 2020; 7: 571227
• 12 Chen P, Wan G, Zhu B. Incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer. J Adv Nurs 2021; 77 (03) 1284-1292
• 13 Hakem R, Soudet S, Diouf M, Sevestre MA. Venous thrombosis recurrence after catheter-related upper extremity deep venous thrombosis in cancer patients: a retrospective analysis. Angiology 2024; 75 (07) 658-665
• 14 Kuderer NM, Poniewierski MS, Culakova E. et al. Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK). Oncologist 2018; 23 (02) 247-255
• 15 Chiari R, Ricciuti B, Landi L. et al. ROS1-rearranged non-small-cell lung cancer is associated with a high rate of venous thromboembolism: analysis from a phase II, prospective, multicenter, two-arms trial (METROS). Clin Lung Cancer 2020; 21 (01) 15-20
• 16 Spencer TR, Mahoney KJ. Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio. J Thromb Thrombolysis 2017; 44 (04) 427-434
• 17 Wang P, He L, Yuan Q. et al. Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer. Thromb J 2024; 22 (01) 6
• 18 Baumann Kreuziger L, Jaffray J, Carrier M. Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults. Thromb Res 2017; 157: 64-71
• 19 Al-Asadi O, Almusarhed M, Eldeeb H. Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single centre cohort study. Thromb J 2019; 17: 2
• 20 Chen Y, Chen H, Yang J. et al. Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy. J Vasc Surg Venous Lymphat Disord 2020; 8 (06) 919-929
• 21 Feng Y, Fu Y, Xiang Q, Xie L, Yu C, Li J. Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study. Support Care Cancer 2021; 29 (11) 6431-6439
• 22 Kang JR, Long LH, Yan SW, Wei WW, Jun HZ, Chen W. Peripherally inserted central catheter-related vein thrombosis in patients with lung cancer. Clin Appl Thromb Hemost 2017; 23 (02) 181-186
• 23 Fan D, Ouyang Z, Ying Y. et al. Thromboelastography for the prevention of perioperative venous thromboembolism in orthopedics. Clin Appl Thromb Hemost 2022;28:10760296221077975
• 24 Tera Y, Suh YJ, Fainchtein K, Agrawal A, Mates M, Othman M. Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy. Am J Hematol 2024; 99 (Suppl. 01) S19-S27
• 25 Yafei Y, Liang Z, Haiping Z, Sheyhidin I, Hui Z. Value of maximum amplitude of thrombus in thromboelastogram in predicting occurrence of venous thrombosis in patients after lung cancer surgery. Chin J Clin Thorac Cardiovasc Surg 2022; 29: 899-903
• 26 Huang Z, Huang DX, Wang YY. et al. Features of thromboelastogram in populations exposed to or transferring from high altitude. Heliyon 2024; 10 (03) e25223
• 27 Drumheller BC, Stein DM, Moore LJ, Rizoli SB, Cohen MJ. Thromboelastography and rotational thromboelastometry for the surgical intensivist: a narrative review. J Trauma Acute Care Surg 2019; 86 (04) 710-721
• 28 Vollmer NJ, Leshko NA, Wilson CS, Gilbert BW. A review of thromboelastography for nurses. Crit Care Nurse 2023; 43 (03) 29-37
• 29 Wang N, Guo Z, Zhang Y. et al. Risk factors analysis of central venous catheter-related thrombosis in critically ill patients and development of nomogram prediction model. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2021; 33 (09) 1047-1051
• 30 Cronin M, Dengler N, Krauss ES. et al. Completion of the updated Caprini risk assessment model (2013 version). Clin Appl Thromb Hemost 2019; 25: 1076029619838052
• 31 Harahsheh Y, Ho KM. Use of viscoelastic tests to predict clinical thromboembolic events: a systematic review and meta-analysis. Eur J Haematol 2018; 100 (02) 113-123
• 32 Brill JB, Badiee J, Zander AL. et al. The rate of deep vein thrombosis doubles in trauma patients with hypercoagulable thromboelastography. J Trauma Acute Care Surg 2017; 83 (03) 413-419
• 33 Gong C, Yu K, Zhang N, Huang J. Predictive value of thromboelastography for postoperative lower extremity deep venous thrombosis in gastric cancer complicated with portal hypertension patients. Clin Exp Hypertens 2021; 43 (02) 196-202
• 34 Li R, Chen N, Ye C, Guo L, Wang E, He Z. Risk factors for postoperative deep venous thrombosis in patients underwent craniotomy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2020; 45 (04) 395-399
• 35 Liu BL, Xie JY, Wang YF. et al. Exploration of the high-risk factors of catheter-related thrombosis in breast cancer. Zhonghua Zhong Liu Za Zhi 2021; 43 (08) 838-842
• 36 Lurie JM, Png CYM, Subramaniam S. et al. Virchow's triad in “silent” deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 2019; 7 (05) 640-645
• 37 Ellis ML, Okano S, McCann A. et al. Catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices. Intern Med J 2020; 50 (12) 1475-1482
• 38 Meng F, Fan S, Guo L, Jia Z, Chang H, Liu F. Incidence and risk factors of PICC-related thrombosis in breast cancer: a meta-analysis. Jpn J Clin Oncol 2024; 54 (08) 863-872
• 39 Peng SY, Wei T, Li XY, Yuan Z, Lin Q. A model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study. Support Care Cancer 2022; 30 (02) 1127-1137
• 40 Martella F, Cerrano M, Di Cuonzo D. et al. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Ann Hematol 2022; 101 (04) 855-867
• 41 Perek S, Khatib A, Izhaki N, Khalaila AS, Brenner B, Horowitz NA. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: a derivation cohort analysis. Eur J Intern Med 2022; 101: 68-75
• 42 Qian H, Liu J, Xu C, Zhu W, Chen L. Predisposing factors and effect of bundle nursing in PICC-related upper extremity deep venous thrombosis in patients with non-Hodgkin's lymphoma undergoing chemotherapy. Am J Transl Res 2021; 13 (08) 9679-9686
• 43 Yuen HLA, Zhao J, Tran H, Chunilal SD. Development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer. Intern Med J 2022; 52 (10) 1733-1740
• 44 Walsh M, Moore EE, Moore H. et al. Use of viscoelastography in malignancy-associated coagulopathy and thrombosis: a review. Semin Thromb Hemost 2019; 45 (04) 354-372
• 45 Idei M, Seino Y, Sato N. et al. Catheter-related thrombosis after cardiac surgery in patients with both central venous and pulmonary artery catheters inserted into the right internal jugular vein: a single-center, prospective, observational study. Heart Vessels 2022; 37 (04) 691-696
• 46 Zhou X, Lin X, Shen R. et al. A retrospective analysis of risk factors associated with catheter-related thrombosis: a single-center study. Perfusion 2020; 35 (08) 806-813
• 47 Chen PT, Chang KC, Hu KL, Ting CK, Chan KH, Chang WK. Catheter-related right internal jugular vein thrombosis after chest surgery. Br J Anaesth 2017; 119 (02) 192-199
• 48 Mpaili E, Tsilimigras DI, Moris D. et al. Utility of viscoelastic coagulation testing in liver surgery: a systematic review. HPB (Oxford) 2021; 23 (03) 331-343
• 49 Wang Y, Cui C, Liu X. et al. Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer. Thorac Cancer 2022; 13 (12) 1814-1821
• 50 Östlund Å, Fläring U, Norberg Å. et al. Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters. Br J Anaesth 2019; 123 (03) 316-324
• 51 Bhargava M, Broccard S, Bai Y, Wu B, Dincer EH, Broccard A. Risk factors for peripherally inserted central catheter line-related deep venous thrombosis in critically ill intensive care unit patients. SAGE Open Med 2020; 8: 2050312120929238
• 52 Liu GD, Ma WJ, Liu HX, Tang L, Tan YH. Risk factors associated with catheter-related venous thrombosis: a meta-analysis. Public Health 2022; 205: 45-54
• 53 Li Z, Lu Z, Lu H, Mei X, Xiaoju Z. Risk factors of peripherally inserted central catheter-related thrombosis in cancer patients. J Nurs (Luton) 2017; 32: 51-55
• 54 Chen L, Lu Y, Wang L, Pan Y, Zhou X. Construction of a nomogram risk prediction model for PICC-related venous thrombosis and its application. Asian J Surg 2024; 47 (01) 107-111
• 55 Ma G, Chen S, Peng S. et al. Construction and validation of a nomogram prediction model for the catheter-related thrombosis risk of central venous access devices in patients with cancer: a prospective machine learning study. J Thromb Thrombolysis 2024; 58 (02) 220-231
• 56 Torimoto K, Okada Y, Tanaka Y. Type 2 diabetes and vascular endothelial dysfunction. J UOEH 2018; 40 (01) 65-75
• 57 Milczarek S, Kulig P, Piotrowska O, Zuchmanska A, Bielikowicz A, Machalinski B. Catheter-related thrombosis in stem cell recipients: comparison of different types of catheter. Haematologica 2024; 109 (04) 1285-1288
• 58 Wang G, Li Y, Wu C. et al. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: a prospective study. Medicine (Baltimore) 2020; 99 (12) e19409
• 59 Chen P, Zhu B, Wan G, Qin L. The incidence of asymptomatic thrombosis related to peripherally inserted central catheter in adults: a systematic review and meta-analysis People's. Nurs Open 2021; 8 (05) 2249-2261
• 60 Liu K, Zhou Y, Xie W. et al. Handgrip exercise reduces peripherally-inserted central catheter-related venous thrombosis in patients with solid cancers: a randomized controlled trial. Int J Nurs Stud 2018; 86: 99-106
• 61 Zhang J, Wu Y, Zhang S. et al. Appraising the quality standard of clinical practice guidelines related to central venous catheter-related thrombosis prevention: a systematic review of clinical practice guidelines. BMJ Open 2024; 14 (03) e074854